Homology Medicines Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
Good morning, everyone, and welcome to the 2021 version of the Credit Suisse Healthcare Conference. We're thrilled to have Homology with us this morning and CEO, Arthur Tzianabos. Why don't I pass it over to Arthur to get started, and if people do have questions, they can certainly shoot an e-mail over to me, and I'll make sure to get those asked, but we'll start out with a presentation from the company.
Great. Thanks, Judah, and thanks to Credit Suisse for the invite to talk to you today on the progress we're making at Homology Medicines. This can -- just to share the slides. So we are a public company, and I will be making forward statements -- looking statements today, and you can check our website for our SEC filings.
This is the mission of the company. We're at a point with technology now and genetic medicines, where we actually have the chance to cure genetic disorders
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
